These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28577949)

  • 121. Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer Cases.
    Suda K; Mitsudomi T; Shintani Y; Okami J; Ito H; Ohtsuka T; Toyooka S; Mori T; Watanabe SI; Asamura H; Chida M; Date H; Endo S; Nagayasu T; Nakanishi R; Miyaoka E; Okumura M; Yoshino I;
    Ann Thorac Surg; 2021 Jan; 111(1):269-276. PubMed ID: 32615091
    [TBL] [Abstract][Full Text] [Related]  

  • 122. The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures.
    He Q; Xin P; Zhang M; Jiang S; Zhang J; Zhong S; Liu Y; Guo M; Chen X; Xia X; Pan Z; Guo C; Cai X; Liang W; He J
    Transl Lung Cancer Res; 2019 Apr; 8(2):124-134. PubMed ID: 31106123
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Increased risk of recurrence in resected EGFR-positive pN0M0 invasive lung adenocarcinoma.
    Ito M; Miyata Y; Kushitani K; Yoshiya T; Kai Y; Tsutani Y; Mimura T; Konishi K; Takeshima Y; Okada M
    Thorac Cancer; 2018 Dec; 9(12):1594-1602. PubMed ID: 30298562
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Prognostic and predictive value of interstitial lung abnormalities and EGFR mutation status in patients with non-small cell lung cancer.
    Xu X; Zhu M; Wang Z; Li J; Ouyang T; Chen C; Huang K; Zhang Y; Gao YL
    Cancer Imaging; 2024 May; 24(1):66. PubMed ID: 38783331
    [TBL] [Abstract][Full Text] [Related]  

  • 125. MR-based radiomics predictive modelling of EGFR mutation and HER2 overexpression in metastatic brain adenocarcinoma: a two-centre study.
    Li Y; Jin Y; Wang Y; Liu W; Jia W; Wang J
    Cancer Imaging; 2024 May; 24(1):65. PubMed ID: 38773634
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Predicting epidermal growth factor receptor mutations in non-small cell lung cancer through dual-layer spectral CT: a prospective study.
    Li F; Qi L; Cheng S; Liu J; Chen J; Cui S; Dong S; Wang J
    Insights Imaging; 2024 Apr; 15(1):109. PubMed ID: 38679659
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Long-term follow-up of a consecutive cohort validating an epidermal growth factor receptor mutation as an independent risk factor for postoperative recurrence in lung adenocarcinoma.
    Matsumura Y; Hayasaka K; Ohira T; Shiono S; Abe J; Notsuda H; Sakurada A; Suzuki H; Okada Y
    Interdiscip Cardiovasc Thorac Surg; 2023 Nov; 37(5):. PubMed ID: 37930012
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Prognosis of recurrence after complete resection in early-stage lung adenocarcinoma based on molecular alterations: a systematic review and meta-analysis.
    Zhou C; Jing Z; Liu W; Ma Z; Liu S; Fang Y
    Sci Rep; 2023 Oct; 13(1):18710. PubMed ID: 37907475
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Non-Small Cell Lung Cancer: Targetable Variants in Concurrent Tissue and Liquid Biopsy Testing in a North Indian Cohort.
    Paturu R; Lingaiah R; Kumari N; Singh S; Krishnani N; Srivastava S; Siddiqui SH; Nath A
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3467-3475. PubMed ID: 37898852
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Clinicopathological Features and Significance of Epidermal Growth Factor Receptor Mutation in Surgically Resected Early-Stage Lung Adenocarcinoma.
    Lu CW; Lin MW; Chiang XH; Hsu HH; Hsieh MS; Chen JS
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766495
    [TBL] [Abstract][Full Text] [Related]  

  • 131. [Correlation Analysis of Ki67 Expression and EGFR Mutation on the Risk of Recurrence and Metastasis in Postoperative Patients with Stage I Lung Adenocarcinoma].
    Xu L; Guo R
    Zhongguo Fei Ai Za Zhi; 2022 Dec; 25(12):852-861. PubMed ID: 36617471
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Dual NGS Comparative Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Samples of Non-Small Cell Lung Carcinoma (NSCLC).
    Buburuzan L; Zamfir Irofei MA; Ardeleanu CM; Muresan AH; Vasilescu F; Hudita A; Costache M; Galateanu B; Puscasu A; Filippi A; Motas N
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551569
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)-A Single Center, Retrospective Observational Study.
    Stephan-Falkenau S; Streubel A; Mairinger T; Kollmeier J; Misch D; Thiel S; Bauer T; Pfannschmidt J; Hollmann M; Wessolly M; Blum TG
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293366
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Structure-based classification of
    Wang T; Cao J; Song Q; Wang L; Xiong Y; Chen R
    J Thorac Dis; 2022 Sep; 14(9):3508-3516. PubMed ID: 36245625
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Different Clinicopathologic and Computed Tomography Imaging Characteristics of Primary and Acquired
    Hou D; Li W; Wang S; Huang Y; Wang J; Tang W; Zhou L; Qi L; Wu N; Zhao S
    Cancer Manag Res; 2021; 13():6389-6401. PubMed ID: 34413682
    [TBL] [Abstract][Full Text] [Related]  

  • 136. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
    Chen A; Ding S; Shen X; Lin X
    Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma.
    Cai L; Wang J; Yan J; Zeng J; Zhu L; Liang J; Pan C; Huang X; Jin J; Xu Y; Wang F; Shao Y; Xu Q; Xia G; Xing M; Xu X; Jiang Y
    Front Oncol; 2020; 10():603671. PubMed ID: 33505917
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Tumor Differentiation and
    Yang L; Pang C; Xu F; Yang G; Xu H; Wang C; Wang Y
    Cancer Manag Res; 2020; 12():12549-12556. PubMed ID: 33324099
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Assessment of Nine Driver Gene Mutations in Surgically Resected Samples from Patients with Non-Small-Cell Lung Cancer.
    Wang S; Qu X; Cao L; Hu X; Hou K; Liu Y; Che X
    Cancer Manag Res; 2020; 12():4029-4038. PubMed ID: 32581578
    [TBL] [Abstract][Full Text] [Related]  

  • 140. The Correlation between EGFR Mutation Status and DNA Content of Lung Adenocarcinoma Cells in Pleural Effusion.
    Du Y; Guo X; Wang R; Ma Y; Zhang Y; Liu Y; Dong L; Wu J; Ji X; Wang H
    J Cancer; 2020; 11(8):2265-2272. PubMed ID: 32127953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.